| The neuropsychopharmacology of cannabis: A review of human imaging studies MAP Bloomfield, C Hindocha, SF Green, MB Wall, R Lees, K Petrilli, ... Pharmacology & therapeutics 195, 132-161, 2019 | 221 | 2019 |
| How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review AM Freeman, K Petrilli, R Lees, C Hindocha, C Mokrysz, HV Curran, ... Neuroscience & Biobehavioral Reviews 107, 696-712, 2019 | 200 | 2019 |
| Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial TP Freeman, C Hindocha, G Baio, NDC Shaban, EM Thomas, D Astbury, ... The Lancet Psychiatry 7 (10), 865-874, 2020 | 157 | 2020 |
| The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls W Lawn, C Mokrysz, R Lees, K Trinci, K Petrilli, M Skumlien, A Borissova, ... Journal of psychopharmacology 36 (12), 1350-1361, 2022 | 21 | 2022 |
| Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls M Skumlien, C Mokrysz, TP Freeman, MB Wall, M Bloomfield, R Lees, ... Neuropsychopharmacology 47 (11), 1976-1983, 2022 | 21 | 2022 |
| Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review R Lees, LA Hines, DC D'Souza, G Stothart, M Di Forti, E Hoch, ... Psychological Medicine 51 (3), 353-364, 2021 | 18 | 2021 |
| Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls M Skumlien, C Mokrysz, TP Freeman, V Valton, MB Wall, M Bloomfield, ... International Journal of Neuropsychopharmacology 26 (1), 9-19, 2023 | 14 | 2023 |
| The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls W Lawn, N Fernandez-Vinson, C Mokrysz, G Hogg, R Lees, K Trinci, ... Psychopharmacology 239 (5), 1629-1641, 2022 | 14 | 2022 |
| The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study MAP Bloomfield, Y Yamamori, C Hindocha, APM Jones, JLL Yim, ... Psychopharmacology 239 (5), 1539-1549, 2022 | 11 | 2022 |
| Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth? KR Thomsen, B Thylstrup, EA Kenyon, R Lees, L Baandrup, SWF Ewing, ... Neuroscience & Biobehavioral Reviews 132, 169-180, 2022 | 11 | 2022 |
| The effects of acute Δ9-tetrahydrocannabinol on striatal glutamatergic function: A proton magnetic resonance spectroscopy study MAP Bloomfield, K Petrilli, R Lees, C Hindocha, K Beck, RJ Turner, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 6 (6), 660-667, 2021 | 5 | 2021 |
| Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder R Lees, LA Hines, C Hindocha, G Baio, NDC Shaban, G Stothart, ... Psychopharmacology 240 (2), 337-346, 2023 | 4 | 2023 |
| Age differences in the behavioural economics of cannabis use: Do adolescents and adults differ on demand for cannabis and discounting of future reward? A Borissova, S Soni, ER Aston, R Lees, K Petrilli, MB Wall, ... Drug and alcohol dependence 238, 109531, 2022 | 4 | 2022 |
| Cognitive fusion as a candidate psychological vulnerability factor for psychosis: An experimental study of acute∆ 9-tetrahydrocannabinol (THC) intoxication K Newman-Taylor, T Richardson, R Lees, K Petrilli, H Bolderston, ... Psychosis 13 (2), 167-174, 2021 | 4 | 2021 |
| Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults N Ertl, W Lawn, C Mokrysz, TP Freeman, N Alnagger, A Borissova, ... Journal of Psychopharmacology 37 (9), 904-919, 2023 | 3 | 2023 |
| Cannabis and cannabidiol use among autistic and non-autistic adults in the UK: a propensity score-matched analysis DYH Hua, R Lees, M Brosnan, TP Freeman BMJ open 11 (12), e053814, 2021 | 3 | 2021 |
| Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder DYH Hua, C Hindocha, G Baio, R Lees, N Shaban, CJ Morgan, A Mofeez, ... Translational Psychiatry 13 (1), 131, 2023 | 2 | 2023 |
| Enhanced cannabis timeline followback (EC‐TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures K Petrilli, W Lawn, R Lees, C Mokrysz, A Borissova, S Ofori, K Trinci, ... Addiction 119 (4), 772-783, 2024 | 1 | 2024 |
| Associations of cannabis use, tobacco use and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis C Burke, TP Freeman, H Sallis, RE Wootton, A Burnley, J Lange, R Lees, ... medRxiv, 2023.03. 17.23287299, 2023 | 1 | 2023 |
Tom P FreemanReader, Addiction and Mental Health Group, Department of Psychology, University of BathE-mailová adresa ověřena na: bath.ac.uk
